Search

Author/Creator Berclaz, Pierre-Yves

1. A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate. Issue 9 (18th April 2013)

Authors:
Genovese, Mark C; Lee, Eric; Satterwhite, Julie; Veenhuizen, Melissa; Disch, Damon; Berclaz, Pierre-Yves; Myers, Stephen; Sides, Gregory; Benichou, Olivier
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Issue 9(2013)
Page Start:
1453
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study. Issue 8 (14th April 2015)

Authors:
Smolen, Josef S; Weinblatt, Michael E; van der Heijde, Désirée; Rigby, William F C; van Vollenhoven, Ronald; Bingham, Clifton O; Veenhuizen, Melissa; Gill, Anne; Zhao, Fangyi; Komocsar, Wendy J; Berclaz, Pierre-Yves; Ortmann, Robert; Lee, Chin
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74:Issue 8(2015)
Page Start:
1567
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study. Issue 1 (12th August 2015)

Authors:
Schiff, Michael; Combe, Bernard; Dörner, Thomas; Kremer, Joel M; Huizinga, Thomas W; Veenhuizen, Melissa; Gill, Anne; Komocsar, Wendy; Berclaz, Pierre-Yves; Ortmann, Robert; Lee, Chin
Journal:
RMD open
Issue:
Volume 1:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and Safety of Tabalumab, an Anti–B-Cell–Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population. Issue 5 (August 2015)

Authors:
Genovese, Mark C.; Silverman, Gregg J.; Emery, Paul; Gupta, Ramesh C.; Gill, Anne; Veenhuizen, Melissa; Xie, Li; Komocsar, Wendy J.; Berclaz, Pierre-Yves; Lee, Chin
Journal:
Journal of clinical rheumatology
Issue:
Volume 21:Issue 5(2015:Aug.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and Safety of Tabalumab, an Anti–B-Cell–Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O). Issue 5 (August 2015)

Authors:
Genovese, Mark C.; Silverman, Gregg J.; Emery, Paul; Gupta, Ramesh C.; Gill, Anne; Veenhuizen, Melissa; Xie, Li; Komocsar, Wendy J.; Berclaz, Pierre-Yves; Lee, Chin
Journal:
Journal of clinical rheumatology
Issue:
Volume 21:Issue 5(2015:Aug.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate. Issue 2 (27th November 2014)

Authors:
Keystone, Edward C; Taylor, Peter C; Drescher, Edit; Schlichting, Douglas E; Beattie, Scott D; Berclaz, Pierre-Yves; Lee, Chin H; Fidelus-Gort, Rosanne K; Luchi, Monica E; Rooney, Terence P; Macias, William L; Genovese, Mark C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74:Issue 2(2015)
Page Start:
333
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. Issue 9 (25th December 2012)

Authors:
Genovese, Mark C; Fleischmann, Roy M; Greenwald, Maria; Satterwhite, Julie; Veenhuizen, Melissa; Xie, Li; Berclaz, Pierre-Yves; Myers, Stephen; Benichou, Olivier
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Issue 9(2013)
Page Start:
1461
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗